SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-062794
Filing Date
2017-12-07
Accepted
2017-12-07 16:29:33
Documents
5
Period of Report
2017-12-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv480950_8k.htm 8-K 29032
2 EXHIBIT 10.1 tv480950_ex10-1.htm EX-10.1 128690
3 EXHIBIT 99.1 tv480950_ex99-1.htm EX-99.1 9463
4 GRAPHIC tv480950_ex10-1img1.jpg GRAPHIC 11180
5 GRAPHIC logo_001.jpg GRAPHIC 5595
  Complete submission text file 0001144204-17-062794.txt   192133
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 617 DETROIT STREET, SUITE 100 ANN ARBOR MI 48104 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12584 | Film No.: 171245081
SIC: 2834 Pharmaceutical Preparations